Information
Integrating World's Genomics Data
MediSapiens makes the world's genomics data usable in health and disease - applied by biopharmaceutical companies in developing next generation personalized medicines and oncologists in choosing optimal cancer treatments.
MediSapiens is based on foundations of molecular biology, company's peer-reviewed cancer data and bioinformatics science since 2004.
User-friendly software
MediSapiens hosts world's largest unified gene expression database of human tissues and diseases, and builds easy-to-use software.
Biopharmaceutical companies benefit from the rich and easy-to-use web interface, analysis libraries and direct access to world's largest unified gene expression data. The comprehensive gene expression reference data flexibly integrates to various external and in-house data sources.
Oncologists achieve personalized cancer care by comparisons to genetic signatures and clinical data from over 20,000 reference patients. The reports reveal individual patient's genetic signature to guide in targeted, personalized cancer care.